Skip to main content
Log in

Safety profile of mycophenolate mofetil: a response

  • Correspondence
  • Published:
Bone Marrow Transplantation Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Basara N, Fauser AA . Safety profile of mycophenolate mofetil Bone Marrow Transplant 2000 26: 1362–1363

    Article  CAS  Google Scholar 

  2. Busca A, Saroglia EM, Lanino E et al. Mycophenolate mofetil (MMF) as therapy for refractory chronic GVHD (cGVHD) in children receiving bone marrow transplantation Bone Marrow Transplant 2000 25: 1067–1071

    Article  CAS  Google Scholar 

  3. Basara N, Blau WI, Romer E et al. Mycophenolate mofetil for the treatment of acute and chronic GVHD in bone marrow transplant patients Bone Marrow Transplant 1998 22: 61–65

    Article  CAS  Google Scholar 

  4. Mookerjee B, Altomonte V, Vogelsang G . Salvage therapy for refractory chronic graft-versus-host disease with mycophenolate mofetil and tacrolimus Bone Marrow Transplant 1999 24: 517–520

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Busca, A., Locatelli, F. & Falda, M. Safety profile of mycophenolate mofetil: a response. Bone Marrow Transplant 27, 892 (2001). https://doi.org/10.1038/sj.bmt.1703018

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.bmt.1703018

  • Springer Nature Limited

This article is cited by

Navigation